688068.SH
热景生物
SSE · Healthcare · Biotechnology · CN
CNY 99.29
−6.76%Year over year
Reported trailing growth
- Revenue
- -12.2%
- EBITDA
- —
- EBIT
- -11.9%
- EPS
- +0.4%
- Free cash flow
- -86.3%
- Operating cash flow
- -55.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -51.5%
- EBITDA
- -45.3%
- EBIT
- -18.7%
- Net income
- -5.0%
- EPS
- -5.9%
- Free cash flow
- +11.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026